Session Details
[P]Retroviridae (Lentivirus)
Mon. Nov 2, 2026 11:00 AM - 5:05 PM JST
Mon. Nov 2, 2026 2:00 AM - 8:05 AM UTC
Mon. Nov 2, 2026 2:00 AM - 8:05 AM UTC
Poster : Retroviridae (Lentivirus) (2F Convention Hall AB)
[P-48]Sector residues in HIV-1 gp41 regulate Env shedding and gp120-gp41 association
*Hien My Thi Chu1, Masaru Yokoyama2, Khanh Quoc Tran1, Bao Quoc Le1, Takaaki Koma1, Naoya Doi1, Yuma Inamoto1, Akio Adachi1, Osamu Kotani2, Hironori Sato2, Masako Nomaguchi1 (1. Tokushima University, 2. Japan Institute of Infectious Diseases)
[P-49]Functional analysis on a packaging signal region of HIV-1.
*Jun-ichi Sakuragi1, Hiroyuki Yamamoto1, Tetsuro Matano1 (1. JIHS-NIID)
[P-50]Drug discovery-oriented analysis of the binding of the HIV-1 Gag MA domain to cardiolipin
*Sho Tomita1, Tomoki Fukuda1, Hiroshi Tateishi2, Takuma Chinen2, Manabu Aoki1, Kazunori Shimagaki2, Fukuda Ryota2, Arisa Sakamoto1,2, Masami Otsuka2, Mikako Fujita2, Kensaku Anraku1 (1. Graduate School of Kumamoto Health Science University, 2. Medicinal and Biological Chemistry Science Farm Joint Research Laboratory)
[P-51]Plasma uridine, adenosine, and inosine: potential biomarkers for inflammation in people living with HIV
*KINUMA SHABANI NDAKI1,2, Mako Toyoda1,2, Yu Nagayoshi3, Godfrey Barabona4, Doreen Kamori4, Takamasa Ueno1,2 (1. Division of Infection and Immunity, Joint Research Center for Human Retrovirus Infection Kumamoto University, Kumamoto, Japan , 2. Graduate School of Medical Sciences of Kumamoto University, 3. Department of Nephrology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan, 4. Department of Microbiology and Immunology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania)
[P-52]Afucosylated anti-HIV-1 V3 antibody controls SHIV and heterologous SIV infection via CD8+ T cell immunity
*Tomotaka Okamura1, Takeo Kuwata2, Natsumi Yasaka3, Kenichi Hanaki1, Shuzo Matsushita2, Yasuhiro Yasutomi4 (1. National Institute of Infectious Diseases, Japan Institute for Health Security, 2. Joint Research Center for Human Retrovirus Infection, Kumamoto University, 3. CURED Inc, 4. Division of Vaccinology for Clinical Development, Institute for Vaccine Research and Development (IVReD), Hokkaido University)
[P-53]Leveraging Nanopore Sequencing for Characterization of HIV-1 Non-B Subtype Diversity and Disease Surveillance.
*Hussein Mti Jumanne1, Mako Toyoda1, Twilumba Makene1, Godfrey Barabona2, Doreen Kamori2, Hirotaka Ode3, Takamasa Ueno1,2 (1. Graduate School of Medical Sciences, Division of Infection and Immunity, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Japan., 2. Department of Microbiology and Immunology, School of Diagnostic Medicine, Tanzania., 3. Clinical Research Center, National Hospital Organization, Nagoya, Aichi, Japan.)
[P-54]Inference of HIV-1 quasi-species haplotypes through nanopore sequencing
*Hirotaka Ode1, Masakazu Matsuda1, Urara Shigemi1, Yoshimi Yamamura1, Yasumasa Iwatani1,2, Yoshiyuki Yokomaku1, Mayumi Imahashi1,3 (1. National Hospital Organization Nagoya Medical Center, 2. Hamamatsu University School of Medicine, 3. Nagoya University Graduate School of Medicine)